Kessler, RC, McGonagle, KA, Zhao, S, Nelson, CB, Hughes, M, Eshleman, S, et al.
Lifetime and 12-month prevalence of DSM-III-R psychiatric
disorders in the United States. Results from the National Comorbidity
Survey. Arch Gen Psychiatry
Judd, LL, Akiskal, HS, Zeller, PJ, Paulus, M, Leon, AC, Maser, JD, et al.
Psychosocial disability during the long-term course of
unipolar major depressive disorder. Arch Gen
2000; 57: 375–80.
World Health Organization. The World Health Report
2001: Mental Health: New Understanding, New Hope.
World Health Organization. The World Health Report
2003: Shaping the Future. WHO,
Lopez, AD, Mathers, CD, Ezzati, M, Jamison, DT, Murray, CJL.
Global and regional burden of disease and risk factors, 2001:
systematic analysis of population health data.
2006; 367: 1747–57.
Ormel, J, Petukhova, M, Chatterji, S, Aguilar-Gaxiola, S, Alonso, J, Angermeyer, MC, et al.
Disability and treatment of specific mental and physical
disorders across the world. Br J
2008; 192: 368–75.
Piccinelli, M, Wilkinson, G.
Outcome of depression in psychiatric
settings. Br J Psychiatry
Pollack, MH, Otto, MW.
Long-term course and outcome of panic
disorder. J Clin Psychiatry
Judd, LL, Akiskal, HS, Maser, JD, Zeller, PJ, Endicott, J, Coryell, W, et al.
A prospective 12-year study of subsyndromal and syndromal
depressive symptoms in unipolar major depressive
disorders. Arch Gen Psychiatry
Social anxiety disorder clinical course and outcome: Review
of Harvard/Brown Anxiety Research Project (HARP)
findings. J Clin Psychiatry
2006; 67: 14–9.
Rhebergen, D, Beekman, ATF, De Graaf, R, Nolen, WA, Spijker, J, Hoogendijk, WJ, et al.
The three-year naturalistic course of major depressive
disorder, dysthymic disorder and double depression.
J Affect Disord
2009; 115: 450–9.
Burns, L, Teesson, M.
Alcohol use disorders comorbid with anxiety, depression and
drug use disorders. Findings from the Australian National Survey of
Mental Health and Well Being. Drug Alcohol
De Graaf, R, Bijl, RV, Smit, F, Vollebergh, WA, Spijker, J.
Risk factors for 12-month comorbidity of mood, anxiety, and
substance use disorders: findings from the Netherlands Mental Health
Survey and Incidence Study. Am J
2002; 159: 620–9.
Hasin, DS, Stinson, FS, Ogburn, E, Grant, BF.
Prevalence, correlates, disability, and comorbidity of DSM-IV
alcohol abuse and dependence in the United States: results from the
National Epidemiologic Survey on Alcohol and Related
Conditions. Arch Gen Psychiatry
2007; 64: 830–42.
Boschloo, L, Vogelzangs, N, Smit, JH, Van den Brink, W, Veltman, DJ, Beekman, AT, et al.
Comorbidity and risk indicators for alcohol use disorders
among persons with anxiety and/or depressive disorders: findings from the
Netherlands Study of Depression and Anxiety (NESDA).
J Affect Disord
2011; 131: 233–42.
Mueller, TI, Lavori, PW, Keller, MB, Swartz, A, Warshaw, M, Hasin, D, et al.
Prognostic effect of the variable course of alcoholism on the
10-year course of depression. Am J
1994; 151: 701–6.
Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, et al.
Influence of psychiatry comorbidity on recovery and
recurrence in generalized anxiety disorder, social phobia, and panic
disorder: a 12-year prospective study. Am J
2005; 162: 1179–87.
Kushner, MG, Sher, KJ, Erickson, DJ.
Prospective analysis of the relation between DSM-III anxiety
disorders and alcohol use disorders. Am J
1999; 156: 723–32.
Muthen, BO, Hasin, DS, Wisnicki, KS.
Factor analysis of ICD-10 symptom items in the 1988 National
Health Interview Survey. Addiction
1993; 88: 1071–7.
Harford, TC, Muthen, BO.
The dimensionality of alcohol abuse and dependence: a
multivariate analysis of DSM-IV symptom items in the National
Longitudinal Survey of Youth. Drug Alcohol
2001; 62: 150–7.
Hasin, DS, Liu, X, Alderson, D, Grant, BF.
DSM-IV alcohol dependence: a categorical or dimensional
phenotype. Psychol Med
2006; 36: 1695–705.
Kessler, RC, Andrews, G, Colpe, LJ, Hiripi, E, Mroczek, DK, Normand, SL, et al.
Short screening scales to monitor population prevalences and
trends in non-specific psychological distress.
2002; 32: 959–76.
Wittchen, HU, Robins, LN, Cottler, LB, Sartorius, N, Burke, JD, Regier, D.
Cross-cultural feasibility, reliability and sources of
variance of the Composite International Diagnostic Interview (CIDI). The
Multicentre WHO/ADAMHA Field Trials. Br J
1991; 159: 645–53, 658.
Penninx, BW, Beekman, AT, Smit, JH, Zitman, FG, Nolen, WA, Spinhoven, P, et al.
The Netherlands Study of Depression and Anxiety (NESDA):
rationale, objectives and methods. Int J Methods
2008; 17: 121–40.
Van der Veen, WJ, Van der Meer, K, Penninx, BW.
Screening for depression and anxiety: correlates of
non-response and cohort attrition in the Netherlands Study of Depression
and Anxiety (NESDA). Int J Methods Psychiatr
2009; 18: 229–39.
Lamers, F, Hoogendoorn, A, Smit, J, Van Dyck, R, Zitman, FG, Nolen, WA, et al.
Sociodemographic and psychiatric determinants of attrition in
the Netherlands Study of Depression and Anxiety (NESDA).
American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th
edn) (DSM-IV). APA,
Rush, AJ, Gullion, CM, Basco, MR, Jarret, RB, Trivedi, MH.
The Inventory of Depressive Symptomatology (IDS):
psychometric properties. Psychol Med
1996; 26: 477–86.
Beck, AT, Epstein, N, Brown, G, Steer, RA.
An inventory for measuring clinical anxiety: psychometric
properties. J Consult Clin Psychol
1988; 56: 893–7.
Cottler, LB, Grant, BF, Blaine, J, Mavreas, V, Pull, C, Hasin, D, et al.
Concordance of DSM-IV alcohol and drug use disorder criteria
and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN.
Drug Alcohol Depend
World Health Organization Collaborating Centre for Drug Statistics
Methodology. Anatomical Therapeutic Chemical (ATC)
Swendsen, JD, Merikangas, KR.
The comorbidity of depression and substance use
disorders. Clin Psychol Rev
2000; 20: 173–89.
Dawson, DA, Saha, TD, Grant, BF.
A multidimensional assessment of the validity and utility of
alcohol use disorder severity as determined by item response theory
models. Drug Alcohol Depend
2010; 107: 31–8.
Approaches for coordinating primary and specialty care for
persons with mental illness. Gen Hosp
Bartels, SJ, Coakley, EH, Zubritsky, C, Ware, JH, Miles, KM, Areán, PA, et al.
Improving access to geriatric mental health services: a
randomized trial comparing treatment engagement with integrated versus
enhanced referral care for depression, anxiety, and at-risk alcohol
use. Am J Psychiatry
2004; 161: 1455–62.
Saunders, JB, Aasland, OF, Babor, TF, Fuente, JRDI, Grant, M.
Development of the Alcohol Use Disorders Identification Test
(AUDIT): WHO Collaborative Project on early detection of persons with
harmful alcohol consumption – II.
Boschloo, L, Vogelzangs, N, Smit, JH, Van den Brink, W, Veltman, DJ, Beekman, ATF, et al.
The performance of the Alcohol Use Disorder Identification
Test (AUDIT) in detecting alcohol abuse and alcohol dependence in a
population of depressed or anxious persons. J
2010; 126: 441–6.
Hasin, DS, Schuckit, MA, Martin, CS, Grant, BF, Bucholz, KK, Helzer, JE.
The validity of DSM-IV alcohol dependence: what do we know
and what do we need to know? Alcohol Clin Exp
2003; 27: 244–52.
Saha, TD, Chou, SP, Grant, BF.
Toward an alcohol use disorder continuum using item response
theory: results from the National Epidemiologic Survey on Alcohol and
Related Conditions. Psychol Med
2006; 36: 931–41.
Hasin, DS, Beseler, CL.
Dimensionality of lifetime alcohol abuse, dependence and
binge drinking. Drug Alcohol Depend
Boschloo, L, Van den Brink, W, Penninx, BWJH, Wall, MM, Hasin, DS.
Alcohol-use disorder severity predicts first-incidence of
depressive disorders. Psychol Med
2011; Aug 26: doi:10.1192/S0033291711001681. Epub ahead of